FDA.reportPublic FDA data

DNA-based tissue typing IVD, control

Definition
A material which is used to verify the performance of an assay intended to be used to evaluate a clinical specimen to diagnose or predict donor and recipient tissue compatibility based on one or multiple genetic markers from the major histocompatibility complex (MHC) family of genes. Genetic markers may include HLA-A, HLA-B, HLA-C, DRB1, DRB3, DRB4, DRB5, DQB1, DPB1, MICA and/or C4.
GUDID devices
8
Last updated
2026-06-04 19:44:10

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
00801902011527ARROWTELEFLEX INCORPORATEDIPN0401682016-09-16
00801902027344ARROWTELEFLEX INCORPORATEDIPN0401702016-09-16
00801902032898ARROWTELEFLEX INCORPORATEDIPN0401722016-09-16
10801902126679ARROWTELEFLEX INCORPORATEDIPN0401712016-09-16
10801902126686ARROWTELEFLEX INCORPORATEDIPN0401732016-09-16
30801902011528ARROWTELEFLEX INCORPORATEDIPN0401682016-09-16
30801902027345ARROWTELEFLEX INCORPORATEDIPN0401702016-09-16
30801902032899ARROWTELEFLEX INCORPORATEDIPN0401722016-09-16